Fluidigm Revolutionizes In Vitro Modeling for Stem Cell Researchers and Cell Biologists

Fluidigm Corporation (NASDAQ:FLDM) today announced its Callisto TM system, a fully automated and programmable microfluidic cell culture system that integrates multifactorial dosing in 32 individual chambers for simultaneous cell culture. This innovative …

[Read the full article here]

Comments are closed.